Olema Pharmaceuticals OLMA Gains Ground as Key Resistance Level Looms US Clean Energy Manufacturing Facilities Projected to Exceed 950 by 2030 Report Finds BOLT Q1 2026 Earnings Deep EPS Miss Highlights Operational Challenges Trump Asks Supreme Court to Intervene on TikTok Ban Citing National Security and Free Speech Concerns PMTV Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Challenging Mortgage Environment GAING Q1 2026 Earnings EPS Misses Estimates by 88 Note Price Edges Higher AIZ Q1 2026 Earnings DoubleDigit EPS Surprise Drives Strong Beat Shares Dip SFBS Q1 2026 Earnings EPS Beats Estimates by a Narrow Margin Amid Steady Performance IRM Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency NMFC Q1 2026 Earnings EPS Misses Consensus by 196 RLX Q1 2026 Earnings EPS Surges Past Estimates Driving Investor Optimism